Phase 2, Double-Blind, Randomized, Controlled Multi-Center Clinical Trial of the Safety and Efficacy of Transplanted Fetal Porcine Cells in Patients With Parkinson's Disease.

This study has been completed.
Sponsor:
Collaborator:
Diacrin/Genzyme Corporation LLC
Information provided by:
Genzyme, a Sanofi Company
ClinicalTrials.gov Identifier:
NCT00226460
First received: September 23, 2005
Last updated: June 18, 2008
Last verified: September 2005
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: January 2001
  Estimated Primary Completion Date: No date given